CO7151504A2 - Metabolites of (1r-trans) -n - [[2- (2,3-dihydro-4-benzofuranyl) cyclopropyl] methyl] propanamide - Google Patents
Metabolites of (1r-trans) -n - [[2- (2,3-dihydro-4-benzofuranyl) cyclopropyl] methyl] propanamideInfo
- Publication number
- CO7151504A2 CO7151504A2 CO14259603A CO14259603A CO7151504A2 CO 7151504 A2 CO7151504 A2 CO 7151504A2 CO 14259603 A CO14259603 A CO 14259603A CO 14259603 A CO14259603 A CO 14259603A CO 7151504 A2 CO7151504 A2 CO 7151504A2
- Authority
- CO
- Colombia
- Prior art keywords
- metabolites
- propanamide
- benzofuranyl
- cyclopropyl
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Abstract
Metabolitos aislados de (1R-trans)-N-[[2-(2,3-dihidro-4-benzofuranilo) ciclopropilo]metilo]propanamida, métodos para su uso, y composiciones que contienen los metabolitos.Metabolites isolated from (1R-trans) -N - [[2- (2,3-dihydro-4-benzofuranyl) cyclopropyl] methyl] propanamide, all for use, and compositions containing the metabolites.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261649220P | 2012-05-18 | 2012-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO7151504A2 true CO7151504A2 (en) | 2014-12-29 |
Family
ID=48483244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO14259603A CO7151504A2 (en) | 2012-05-18 | 2014-11-25 | Metabolites of (1r-trans) -n - [[2- (2,3-dihydro-4-benzofuranyl) cyclopropyl] methyl] propanamide |
Country Status (18)
Country | Link |
---|---|
US (4) | US9212129B2 (en) |
EP (1) | EP2855424B1 (en) |
JP (1) | JP5959083B2 (en) |
KR (3) | KR20150005691A (en) |
CN (2) | CN108997160A (en) |
AU (1) | AU2013262631B2 (en) |
BR (1) | BR112014028446A2 (en) |
CA (1) | CA2872324C (en) |
CL (1) | CL2014003126A1 (en) |
CO (1) | CO7151504A2 (en) |
ES (1) | ES2648987T3 (en) |
IL (1) | IL235485A (en) |
IN (1) | IN2014DN10691A (en) |
MX (1) | MX2014014010A (en) |
NZ (1) | NZ701515A (en) |
RU (1) | RU2632889C2 (en) |
WO (1) | WO2013173707A1 (en) |
ZA (1) | ZA201408014B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2632889C2 (en) | 2012-05-18 | 2017-10-11 | Ванда Фармасьютиклз Инк. | Metabolites (1r-trans)-n-[[2-(2,3-digidro-4-benzofuranyl)cyclopropyl]-methyl]propanamide |
WO2015117048A1 (en) * | 2014-01-31 | 2015-08-06 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
JP2022500420A (en) * | 2018-09-12 | 2022-01-04 | バンダ・ファーマシューティカルズ・インコーポレイテッドVanda Pharmaceuticals Inc. | Improving sleep or post-sleep performance |
CA3129833C (en) * | 2019-02-13 | 2023-01-17 | Vanda Pharmaceuticals Inc. | Method of improving sleep |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2176854A1 (en) | 1995-06-07 | 1996-12-08 | Daniel J. Keavy | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
PT1027043E (en) | 1996-12-10 | 2005-02-28 | Bristol Myers Squibb Co | BENZODIOXOLE BENZOFURANO DI-HYDROBENZOFURAN AND BENZODIOXAN AS MELATONERGIC AGENTS |
CN101912367A (en) | 2001-10-30 | 2010-12-15 | 诺瓦提斯公司 | The depot formulation of iloperidone and star-shape polymer |
GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
JP2009538331A (en) * | 2006-05-22 | 2009-11-05 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | Treatment for depression disorders |
KR20180100450A (en) * | 2012-01-26 | 2018-09-10 | 반다 파마슈티칼즈, 인코퍼레이티드. | Treatment of circadian rhythm disorders |
RU2632889C2 (en) * | 2012-05-18 | 2017-10-11 | Ванда Фармасьютиклз Инк. | Metabolites (1r-trans)-n-[[2-(2,3-digidro-4-benzofuranyl)cyclopropyl]-methyl]propanamide |
-
2013
- 2013-05-17 RU RU2014151161A patent/RU2632889C2/en active
- 2013-05-17 MX MX2014014010A patent/MX2014014010A/en active IP Right Grant
- 2013-05-17 WO PCT/US2013/041573 patent/WO2013173707A1/en active Application Filing
- 2013-05-17 ES ES13724708.6T patent/ES2648987T3/en active Active
- 2013-05-17 EP EP13724708.6A patent/EP2855424B1/en active Active
- 2013-05-17 NZ NZ701515A patent/NZ701515A/en unknown
- 2013-05-17 IN IN10691DEN2014 patent/IN2014DN10691A/en unknown
- 2013-05-17 CN CN201811055156.4A patent/CN108997160A/en active Pending
- 2013-05-17 AU AU2013262631A patent/AU2013262631B2/en active Active
- 2013-05-17 KR KR1020147033530A patent/KR20150005691A/en not_active Application Discontinuation
- 2013-05-17 CN CN201380025225.6A patent/CN104583178A/en active Pending
- 2013-05-17 BR BR112014028446A patent/BR112014028446A2/en not_active Application Discontinuation
- 2013-05-17 KR KR1020187023795A patent/KR20180095737A/en active Search and Examination
- 2013-05-17 US US14/401,857 patent/US9212129B2/en active Active
- 2013-05-17 JP JP2015512886A patent/JP5959083B2/en active Active
- 2013-05-17 KR KR1020177015054A patent/KR101891299B1/en active IP Right Grant
- 2013-05-17 CA CA2872324A patent/CA2872324C/en active Active
-
2014
- 2014-11-03 ZA ZA2014/08014A patent/ZA201408014B/en unknown
- 2014-11-03 IL IL235485A patent/IL235485A/en active IP Right Grant
- 2014-11-18 CL CL2014003126A patent/CL2014003126A1/en unknown
- 2014-11-25 CO CO14259603A patent/CO7151504A2/en unknown
-
2015
- 2015-11-10 US US14/937,786 patent/US9617203B2/en active Active
-
2017
- 2017-03-02 US US15/447,946 patent/US9850199B2/en active Active
- 2017-12-08 US US15/836,099 patent/US10233142B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016000925A1 (en) | Bromodomain inhibitors | |
UY34220A (en) | INDAZOLS, PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME | |
CL2017001923A1 (en) | 9h-pyrrolo-dipyridine derivatives | |
CU20180059A7 (en) | INHIBITING COMPOUNDS OF THE QUINASA DE UNIÓN A TANK | |
CL2016002877A1 (en) | Compounds of 2-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine, compositions and methods of use thereof. | |
UY35485A (en) | HETEROCYCLIC COMPOUNDS AND USES OF THE SAME | |
UY34632A (en) | OXAZOLIDIN- 2- ONA COMPOUNDS AND USES OF THE SAME | |
CR20180072A (en) | NEW BICYCLE COMPOUNDS AS ATX INHIBITORS | |
DOP2015000219A (en) | HETEROARILO COMPOUNDS AND ITS USES | |
CR20180057A (en) | NEW BICYCLE COMPOUNDS AS DUAL INHIBITORS OF ATX / CA. | |
GT201300152A (en) | AMINOINDAN AMIDAS WITH HIGH FUNGICIDE ACTIVITY AND ITS PHYTOSANITARY COMPOSITIONS | |
CR20150549A (en) | HETEROCYCLIC COMPOUNDS AND THEIR USES | |
UY35467A (en) | ORGANIC COMPOUNDS | |
GT201700023A (en) | OPTIONALLY CONDENSED HYDERO-CYCLIC DERIVATIVES OF PIRIDIMINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOINMUNITY DISEASES | |
UY31806A (en) | TIAZOLE AND OXAZOLE COMPOUNDS OF BENZENE SULFONAMIDE | |
CU24315B1 (en) | NEW DERIVATIVES OF 5- (2- {[3- (AMINOMETIL) -3,4-DIHYDROISOQUIN0-2 (1 H) IL] CARBONIL} PHENYL) -1 H-PIRROL-3-CARBOXAMIDE AS BCL-2 INHIBITORS AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
CL2017003107A1 (en) | 2- (Pyrazolopyridin-3-yl) pyrimidine derivatives as jak inhibitors | |
UY34797A (en) | BICYCLICALLY REPLACED URACILES AND USE OF THE SAME | |
CL2014003472A1 (en) | Pro-drugs derived from (e) -n-methyl-n - ((3-methylbenzofuran-2-yl) methyl) -3- (7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridine -3-yl) acrylamide; pharmaceutical composition that includes them; and its use to treat a bacterial infection. | |
UY34111A (en) | NEW AGOMELATINE CO-CRYSTALS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
ECSP11011344A (en) | NEW ANTIBODIES ANTI-? 5? 1 AND ITS USES | |
CL2017002856A1 (en) | Thioether compounds as nitrification inhibitors | |
CO6940429A2 (en) | Heterocyclic compounds, medicines that contain them, use of those and processes for their preparation | |
NI201400042A (en) | 2 - THIOPYRIMIDINONES | |
UY34018A (en) | GLUCOSIDE DERIVATIVES AND USES OF THE SAME |